Nipple reconstruction implant
US-2024238077-A1 · Jul 18, 2024 · US
US9468521B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9468521-B2 |
| Application number | US-201414456761-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 11, 2014 |
| Priority date | Dec 15, 2011 |
| Publication date | Oct 18, 2016 |
| Grant date | Oct 18, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Methods for breast reconstruction and augmentation are provided which may reduce the incidence of capsular contracture. Methods for treating an encapsulated breast and reducing potential for capsular contracture in the breast are also provided.
Opening claim text (preview).
What is claimed is: 1. A method for treating a breast at risk for capsule contracture, the breast having an encapsulated prosthesis therein, the method comprising the steps of: removing the encapsulated prosthesis from the breast to form a breast cavity and leaving the capsule tissue substantially intact in the breast; and introducing a different prosthesis into the breast cavity, the different prosthesis having a porous surface defined by open-celled, interconnected pores having an average pore size of greater than about 600 μm; whereby the porous surface of the different prosthesis causes disorganization of the capsule tissue in contact therewith, and reduced risk of capsule contracture. 2. The method of claim 1 wherein the different prosthesis has non-bioresorbable surface. 3. The method of claim 1 wherein the different prosthesis has an elastomeric silicone surface. 4. The method of claim 1 wherein the different prosthesis has a non-bioresorbable, elastomeric silicone surface. 5. The method of claim 1 wherein the encapsulated prosthesis is a smooth surface prosthesis.
Mammary prostheses · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.